[go: up one dir, main page]

MX2012014970A - Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso. - Google Patents

Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso.

Info

Publication number
MX2012014970A
MX2012014970A MX2012014970A MX2012014970A MX2012014970A MX 2012014970 A MX2012014970 A MX 2012014970A MX 2012014970 A MX2012014970 A MX 2012014970A MX 2012014970 A MX2012014970 A MX 2012014970A MX 2012014970 A MX2012014970 A MX 2012014970A
Authority
MX
Mexico
Prior art keywords
ezetimibe
pharmaceutical compositions
rosuvastatin calcium
amorphous rosuvastatin
novel amorphous
Prior art date
Application number
MX2012014970A
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Podili Khadgapathi
Kumar Madallapalli Kiran
Original Assignee
Hetlabs Mexico S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetlabs Mexico S A De C V filed Critical Hetlabs Mexico S A De C V
Priority to MX2012014970A priority Critical patent/MX2012014970A/es
Publication of MX2012014970A publication Critical patent/MX2012014970A/es

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a un proceso para preparar una combinación farmacéutica de dosis fija que comprende (a) ezetimibe con un tamaño de partícula d90 menor a 10 µm, (b) rosuvastatina de calcio amorfo.
MX2012014970A 2012-12-18 2012-12-18 Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso. MX2012014970A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2012014970A MX2012014970A (es) 2012-12-18 2012-12-18 Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012014970A MX2012014970A (es) 2012-12-18 2012-12-18 Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso.

Publications (1)

Publication Number Publication Date
MX2012014970A true MX2012014970A (es) 2013-08-27

Family

ID=49552931

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012014970A MX2012014970A (es) 2012-12-18 2012-12-18 Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso.

Country Status (1)

Country Link
MX (1) MX2012014970A (es)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015044698A3 (en) * 2013-09-30 2015-05-14 Egis Gyógyszergyár Zrt. Medical composition containing a cholesterol absorption inhibitor and cholesterol biosynthesis inhibitor
CN105873571A (zh) * 2013-12-30 2016-08-17 韩美药品株式会社 包含依泽替米贝和瑞舒伐他汀的口服复合制剂
WO2018041282A1 (en) * 2016-09-05 2018-03-08 Zentiva, K.S. A pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof
WO2018041281A1 (en) * 2016-09-05 2018-03-08 Zentiva, K.S. A pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof
WO2021019499A1 (en) 2019-07-31 2021-02-04 TECNIMEDE - Sociedade Técnico-medicinal, SA Solid oral multiple-unit immediate release compositions, methods and uses thereof

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015044698A3 (en) * 2013-09-30 2015-05-14 Egis Gyógyszergyár Zrt. Medical composition containing a cholesterol absorption inhibitor and cholesterol biosynthesis inhibitor
CN105722505A (zh) * 2013-09-30 2016-06-29 埃吉斯药物私人有限公司 含有胆固醇吸收抑制剂和胆固醇生物合成抑制剂的药物组合物
CN114796148A (zh) * 2013-09-30 2022-07-29 埃吉斯药物私人有限公司 含有胆固醇吸收抑制剂和胆固醇生物合成抑制剂的药物组合物
EA034711B1 (ru) * 2013-09-30 2020-03-12 Эгиш Дьёдьсердьяр Зрт. Лекарственная композиция, содержащая ингибитор всасывания холестерина и ингибитор биосинтеза холестерина
AU2014374552B2 (en) * 2013-12-30 2019-09-19 Hanmi Pharm. Co., Ltd. Composite formulation for oral administration comprising ezetimibe and rosuvastatin
US10434067B2 (en) 2013-12-30 2019-10-08 Hanmi Pharm. Co., Ltd. Composite formulation for oral administration comprising ezetimibe and rosuvastatin
CN105873571B (zh) * 2013-12-30 2019-10-22 韩美药品株式会社 包含依泽替米贝和瑞舒伐他汀的口服复合制剂
EP3089739A4 (en) * 2013-12-30 2017-08-02 Hanmi Pharm. Co., Ltd. Composite formulation for oral administration comprising ezetimibe and rosuvastatin
CN105873571A (zh) * 2013-12-30 2016-08-17 韩美药品株式会社 包含依泽替米贝和瑞舒伐他汀的口服复合制剂
WO2018041281A1 (en) * 2016-09-05 2018-03-08 Zentiva, K.S. A pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof
WO2018041282A1 (en) * 2016-09-05 2018-03-08 Zentiva, K.S. A pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof
CN110418637A (zh) * 2016-09-05 2019-11-05 赛诺菲 包含瑞舒伐他汀和依泽替米贝的药物组合物及其制备方法
US11786526B2 (en) 2016-09-05 2023-10-17 Sanofi Pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof
WO2021019499A1 (en) 2019-07-31 2021-02-04 TECNIMEDE - Sociedade Técnico-medicinal, SA Solid oral multiple-unit immediate release compositions, methods and uses thereof

Similar Documents

Publication Publication Date Title
IN2013CN09704A (es)
MX2015002487A (es) Proceso para la preparacion de teneligliptina.
MY194466A (en) Heterophasic polypropylene composition
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
IN2014DN06964A (es)
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
IN2013MU03641A (es)
MX2016015464A (es) Composicion farmaceutica oral de isotretinoina.
MX2012014970A (es) Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso.
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
MX2015003034A (es) Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso.
PH12014501840A1 (en) Pharmaceutical formulation having improved stability
PH12013500210A1 (en) Highly crystalline valsartan
IL245260A0 (en) Non-aqueous crystalline form of cabazitaxel, process for its preparation and pharmaceutical compositions thereof
MY181682A (en) Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it
WO2014030173A3 (en) Improved process for preparation of atazanavir bisulfate
IN2013CH04314A (es)
EP3050575A4 (en) Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
SI2872135T1 (sl) Postopek za izdelavo šipkovega prahu
WO2014102670A3 (en) Process for preparing amorphous cabazitaxel
IN2013MU02528A (es)
IN2012CH02984A (es)
IN2013MU01226A (es)
IN2013CH05769A (es)
IN2013CH05770A (es)